OpenURL Connection Search

Select item for more details and to access through your institution.

Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats.
Published in:
European Spine Journal, 2006, v. 15, n. 2, p. 234, doi. 10.1007/s00586-005-0981-8
By:
- Rochkind, S.;
- Shahar, A.;
- Fliss, D.;
- El-Ani, D.;
- Astachov, L.;
- Hayon, T.;
- Alon, M.;
- Zamostiano, R.;
- Ayalon, O.;
- Biton, I. E.;
- Cohen, Y.;
- Halperin, R.;
- Schneider, D.;
- Oron, A.;
- Nevo, Z.
Publication type:
Article
A Novel VIP Responsive Gene: Activity Dependent Neuroprotective Protein.
Published in:
Annals of the New York Academy of Sciences, 2000, v. 921, n. 1, p. 115, doi. 10.1111/j.1749-6632.2000.tb06957.x
By:
- GOZES, I.;
- ZAMOSTIANO, R.;
- PINHASOV, A.;
- BASSAN, M.;
- GILADI, E.;
- STEINGART, R. A.;
- BRENNEMAN, D. E.
Publication type:
Article
Neuropeptides and Neuronal Survival: Neuroprotective Strategy for Alzheimer's Disease<sup>a</sup>.
Published in:
Annals of the New York Academy of Sciences, 1997, v. 814, n. 1, p. 161, doi. 10.1111/j.1749-6632.1997.tb46154.x
By:
- GOZES, I.;
- BARDEA, A.;
- BECHAR, M.;
- PEARL, O.;
- RESHEF, A.;
- ZAMOSTIANO, R.;
- DAVIDSON, A.;
- RUBINRAUT, S.;
- GILADI, E.;
- FRIDKIN, M.;
- BRENNEMAN, D. E.
Publication type:
Article
Development of VIP Agonists and Antagonists with Tissue and Receptor Specificity: Effects on Behavioral Maturation, Sexual Function, and the Biologic Clock<sup>a</sup>.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 805, n. 1, p. 159, doi. 10.1111/j.1749-6632.1996.tb17481.x
By:
- GOZES, I.;
- LILLING, G.;
- DAVIDSON, A.;
- BARDEA, A.;
- RESHEF, A.;
- GLAZER, R.;
- ZAMOSTIANO, R.;
- ASHUR-FABIAN, O.;
- TICHER, A.;
- ASHKENAZI, I. E.;
- MOODY, T. W.;
- RUBINRAUT, S.;
- FRIDKIN, M.;
- BRENNEMAN, D. E.
Publication type:
Article

Found: 4

Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats.

A Novel VIP Responsive Gene: Activity Dependent Neuroprotective Protein.

Neuropeptides and Neuronal Survival: Neuroprotective Strategy for Alzheimer's Disease<sup>a</sup>.

Development of VIP Agonists and Antagonists with Tissue and Receptor Specificity: Effects on Behavioral Maturation, Sexual Function, and the Biologic Clock<sup>a</sup>.